Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Sep 14, 2011, 03:56 ET from Reportlinker

NEW YORK, Sept. 14, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

http://www.reportlinker.com/p0611589/Orthobiologics-Market-Outlook-in-BRICS-Brazil-Russia-India-China-South-Africa-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biomaterial

Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Summary

GlobalData's new report, "Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017" provides key market data on the Orthobiologics market in the BRICS countries. The report provides value ($m) data for each segment within four market categories – Bone Graft Substitutes, Bone Allografts, Viscosupplementation and Bone Growth Stimulators. The report also provides company shares and distribution shares data for the overall Orthobiologics market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world's most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It's estimated that shortly after 2020, India's population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Scope

- Market size data for Orthobiologics market categories – Bone Graft Substitutes, Bone Allografts, Viscosupplementation and Bone Growth Stimulators.

- Annualized market revenues ($m) data for each of the segments and sub-segments within the four market categories. Data from 2003 to 2010, forecast forward for seven years to 2017.

- 2010 company shares and distribution shares data for the overall Orthobiologics market in each of the aforementioned countries.

- Global corporate-level profiles of key companies operating within the Orthobiologics market in BRICS.

- Key players covered include DePuy, Inc., Genzyme Corporation, Synthes, Inc., Orthofix International N.V., Medtronic, Inc., Biomet, Inc., DJO Incorporated, Smith & Nephew Plc, Baxter International Inc., Stryker Corporation, Globus Medical, Inc. and WRIGHT MEDICAL GROUP, INC.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Orthobiologics competitive landscape in BRICS.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 8

1.2 List of Figures 13

2 Introduction 17

2.1 What is This Report About? 17

3 Orthobiologics in BRICS 18

3.1 Orthobiologics, BRICS, Overall Revenue ($m), 2003-2017 18

3.2 Orthobiologics, BRICS, Category Volume (Units), 2003-2017 24

3.3 Orthobiologics, BRICS, Company share (2009-2010) 29

4 Orthobiologics In Brazil 31

4.1 Orthobiologics, Brazil, Overall Revenue ($m), 2003-2017 31

4.2 Orthobiologics, Brazil, Category Volume (Units), 2003-2017 37

4.3 Bone Allografts in Brazil 41

4.3.1 Bone Allografts, Brazil, Overall Revenue (2003-2017) 41

4.4 Bone Graft Substitutes in Brazil 43

4.4.1 Bone Graft Substitutes, Brazil, Overall Revenue (2003-2017) 43

4.4.2 Bone Graft Substitutes, Brazil, Overall Volume (2003-2017) 47

4.4.3 Bone Graft Substitutes, Brazil, Average Price (2003-2017) 51

4.5 Viscosupplementation in Brazil 52

4.5.1 Viscosupplementation, Brazil, Overall Revenue (2003-2017) 52

4.5.2 Viscosupplementation, Brazil, Overall Volume (2003-2017) 54

4.5.3 Viscosupplementation, Brazil, Average Price (2003-2017) 56

4.6 Bone Growth Stimulators in Brazil 57

4.6.1 Bone Growth Stimulators, Brazil, Overall Revenue (2003-2017) 57

4.6.2 Bone Growth Stimulators, Brazil, Overall Volume (2003-2017) 59

4.6.3 Bone Growth Stimulators, Brazil, Average Price (2003-2017) 61

4.7 Orthobiologics, Brazil, Distribution Share (2009-2010) 62

4.8 Orthobiologics, Brazil, Company Share (2009-2010) 63

5 Orthobiologics In Russian Federation 65

5.1 Orthobiologics, Russian Federation, Overall Revenue ($m), 2003-2017 65

5.2 Orthobiologics, Russian Federation, Category Volume (Units), 2003-2017 71

5.3 Bone Graft Substitutes in Russian Federation 76

5.3.1 Bone Graft Substitutes, Russian Federation, Overall Revenue (2003-2017) 76

5.3.2 Bone Graft Substitutes, Russian Federation, Overall Volume (2003-2017) 80

5.3.3 Bone Graft Substitutes, Russian Federation, Average Price (2003-2017) 84

5.4 Bone Allografts in Russian Federation 85

5.4.1 Bone Allografts, Russian Federation, Overall Revenue (2003-2017) 85

5.5 Viscosupplementation in Russian Federation 87

5.5.1 Viscosupplementation, Russian Federation, Overall Revenue (2003-2017) 87

5.5.2 Viscosupplementation, Russian Federation, Overall Volume (2003-2017) 89

5.5.3 Viscosupplementation, Russian Federation, Average Price (2003-2017) 91

5.6 Bone Growth Stimulators In Russian Federation 92

5.6.1 Bone Growth Stimulators, Russian Federation, Overall Revenue (2003-2017) 92

5.6.2 Bone Growth Stimulators, Russian Federation, Overall Volume (2003-2017) 94

5.6.3 Bone Growth Stimulators, Russian Federation, Average Price (2003-2017) 96

5.7 Orthobiologics, Russian Federation, Distribution Share (2009-2010) 97

5.8 Orthobiologics, Russian Federation, Company Share (2009-2010) 98

6 Orthobiologics In India 100

6.1 Orthobiologics, India, Overall Revenue ($m), 2003-2017 100

6.2 Orthobiologics, India, Category Volume (Units), 2003-2017 106

6.3 Bone Graft Substitutes in India 110

6.3.1 Bone Graft Substitutes, India, Overall Revenue (2003-2017) 110

6.3.2 Bone Graft Substitutes, India, Overall Volume (2003-2017) 114

6.3.3 Bone Graft Substitutes, India, Average Price (2003-2017) 117

6.4 Viscosupplementation In India 118

6.4.1 Viscosupplementation, India, Overall Revenue (2003-2017) 118

6.4.2 Viscosupplementation, India, Overall Volume (2003-2017) 120

6.4.3 Viscosupplementation, India, Average Price (2003-2017) 122

6.5 Bone Allografts In India 123

6.5.1 Bone Allografts, India, Overall Revenue (2003-2017) 123

6.6 Bone Growth Stimulators in India 125

6.6.1 Bone Growth Stimulators, India, Overall Revenue (2003-2017) 125

6.6.2 Bone Growth Stimulators, India, Overall Volume (2003-2017) 127

6.6.3 Bone Growth Stimulators, India, Average Price (2003-2017) 129

6.7 Orthobiologics, India, Distribution Share (2009-2010) 130

6.8 Orthobiologics, India, Company Share (2009-2010) 131

7 Orthobiologics In China 133

7.1 Orthobiologics, China, Overall Revenue ($m), 2003-2017 133

7.2 Orthobiologics, China, Category Volume (Units), 2003-2017 139

7.3 Bone Graft Substitutes In China 144

7.3.1 Bone Graft Substitutes, China, Overall Revenue (2003-2017) 144

7.3.2 Bone Graft Substitutes, China, Overall Volume (2003-2017) 148

7.3.3 Bone Graft Substitutes, China, Average Price (2003-2017) 152

7.4 Bone Allografts in China 153

7.4.1 Bone Allografts, China, Overall Revenue (2003-2017) 153

7.5 Viscosupplementation In China 155

7.5.1 Viscosupplementation, China, Overall Revenue (2003-2017) 155

7.5.2 Viscosupplementation, China, Overall Volume (2003-2017) 157

7.5.3 Viscosupplementation, China, Average Price (2003-2017) 159

7.6 Bone Growth Stimulators In China 160

7.6.1 Bone Growth Stimulators, China, Overall Revenue (2003-2017) 160

7.6.2 Bone Growth Stimulators, China, Overall Volume (2003-2017) 162

7.6.3 Bone Growth Stimulators, China, Average Price (2003-2017) 164

7.7 Orthobiologics, China, Distribution Share (2009-2010) 165

7.8 Orthobiologics, China, Company Share (2009-2010) 166

8 Orthobiologics In South Africa 168

8.1 Orthobiologics, South Africa, Overall Revenue ($m), 2003-2017 168

8.2 Orthobiologics, South Africa, Category Volume (Units), 2003-2017 174

8.3 Viscosupplementation In South Africa 179

8.3.1 Viscosupplementation, South Africa, Overall Revenue (2003-2017) 179

8.3.2 Viscosupplementation, South Africa, Overall Volume (2003-2017) 181

8.3.3 Viscosupplementation, South Africa, Average Price (2003-2017) 183

8.4 Bone Graft Substitutes in South Africa 184

8.4.1 Bone Graft Substitutes, South Africa, Overall Revenue (2003-2017) 184

8.4.2 Bone Graft Substitutes, South Africa, Overall Volume (2003-2017) 188

8.4.3 Bone Graft Substitutes, South Africa, Average Price (2003-2017) 191

8.5 Bone Allografts in South Africa 192

8.5.1 Bone Allografts, South Africa, Overall Revenue (2003-2017) 192

8.6 Bone Growth Stimulators In South Africa 194

8.6.1 Bone Growth Stimulators, South Africa, Overall Revenue (2003-2017) 194

8.6.2 Bone Growth Stimulators, South Africa, Overall Volume (2003-2017) 196

8.6.3 Bone Growth Stimulators, South Africa, Average Price (2003-2017) 198

8.7 Orthobiologics, South Africa, Distribution Share (2009-2010) 199

8.8 Orthobiologics, South Africa, Company Share (2009-2010) 200

9 Overview of Key Companies in BRICS Orthobiologics Market 202

9.1 DePuy, Inc. 202

9.1.1 Company Overview 202

9.1.2 Share in the BRICS Orthobiologics Market 203

9.2 Genzyme Corporation 204

9.2.1 Company Overview 204

9.2.2 Share in the BRICS Orthobiologics Market 205

9.3 Synthes, Inc. 206

9.3.1 Company Overview 206

9.3.2 Share in the BRICS Orthobiologics Market 207

9.4 Orthofix International N.V. 208

9.4.1 Company Overview 208

9.4.2 Share in the BRICS Orthobiologics Market 209

9.5 Medtronic, Inc. 210

9.5.1 Company Overview 210

9.5.2 Share in the BRICS Orthobiologics Market 211

9.6 Biomet, Inc. 212

9.6.1 Company Overview 212

9.6.2 Share in the BRICS Orthobiologics Market 213

9.7 DJO Incorporated 214

9.7.1 Company Overview 214

9.7.2 Share in the BRICS Orthobiologics Market 215

9.8 Smith & Nephew Plc 216

9.8.1 Company Overview 216

9.8.2 Share in the BRICS Orthobiologics Market 217

9.9 Baxter International Inc. 218

9.9.1 Company Overview 218

9.9.2 Share in the BRICS Orthobiologics Market 219

9.10 Stryker Corporation 220

9.10.1 Company Overview 220

9.10.2 Share in the BRICS Orthobiologics Market 221

9.11 Globus Medical, Inc. 222

9.11.1 Company Overview 222

9.11.2 Share in the BRICS Orthobiologics Market 222

9.12 Wright Medical Group, Inc 223

9.12.1 Company Overview 223

9.12.2 Share in the BRICS Orthobiologics Market 224

9.13 Alphatec Holdings, Inc. 225

9.13.1 Company Overview 225

9.14 Ferring Pharmaceuticals 225

9.14.1 Company Overview 225

9.15 Seikagaku Corporation 225

9.15.1 Company Overview 225

9.16 Osteotech, Inc. (Inactive) 226

9.16.1 Company Overview 226

10 Appendix 227

10.1 Definitions of Markets Covered in the Report 228

10.1.1 Orthobiologics 228

10.2 Research Methodology 230

10.3 Secondary Research 230

10.4 Primary Research 231

10.5 Models 231

10.6 Forecasts 232

10.7 Expert Panels 232

10.8 GlobalData Consulting 232

10.9 Currency Conversion 233

10.10 Contact Us 233

10.11 Disclaimer 233

1.1 List of Tables

Table 1: Orthobiologics, BRICS, Overall Revenue ($m), 2003-2017 19

Table 2: Orthobiologics, BRICS, Overall Revenue ($m), Historic, 2003-2010 21

Table 3: Orthobiologics, BRICS, Overall Revenue ($m), Forecast, 2010-2017 23

Table 4: Orthobiologics, BRICS, Category Volume (Units), 2003-2017 24

Table 5: Orthobiologics, BRICS, Category Volume (Units), Historic, 2003-2010 26

Table 6: Orthobiologics, BRICS, Category Volume (Units), Forecast, 2010-2017 28

Table 7: Orthobiologics, BRICS, Company share by Revenue ($m), 2009-2010 30

Table 8: Orthobiologics, Brazil, Overall Revenue ($m), 2003-2017 32

Table 9: Orthobiologics, Brazil, Overall Revenue ($m), Historic, 2003-2010 34

Table 10: Orthobiologics, Brazil, Overall Revenue ($m), Forecast, 2010-2017 36

Table 11: Orthobiologics, Brazil, Category Volume (Units), 2003-2017 37

Table 12: Orthobiologics, Brazil, Category Volume (Units), Historic, 2003-2010 39

Table 13: Orthobiologics, Brazil, Category Volume (Units), Forecast, 2010-2017 40

Table 14: Bone Allografts, Brazil, Revenue ($m), Historic, 2003-2010 41

Table 15: Bone Allografts, Brazil, Revenue ($m), Forecast, 2010-2017 42

Table 16: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 44

Table 17: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 46

Table 18: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2003-2010 48

Table 19: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2010-2017 50

Table 20: Bone Graft Substitutes, Brazil, Average Price ($), Historic, 2003-2010 51

Table 21: Bone Graft Substitutes, Brazil, Average Price ($), Forecast, 2010-2017 51

Table 22: Viscosupplementation, Brazil, Revenue ($m), Historic, 2003-2010 52

Table 23: Viscosupplementation, Brazil, Revenue ($m), Forecast, 2010-2017 53

Table 24: Viscosupplementation, Brazil, Volume (Units), Historic, 2003-2010 54

Table 25: Viscosupplementation, Brazil, Volume (Units), Forecast, 2010-2017 55

Table 26: Viscosupplementation, Brazil, Average Price ($), Historic, 2003-2010 56

Table 27: Viscosupplementation, Brazil, Average Price ($), Forecast, 2010-2017 56

Table 28: Bone Growth Stimulators, Brazil, Revenue ($m), Historic, 2003-2010 57

Table 29: Bone Growth Stimulators, Brazil, Revenue ($m), Forecast, 2010-2017 58

Table 30: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2003-2010 59

Table 31: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2010-2017 60

Table 32: Bone Growth Stimulators, Brazil, Average Price ($), Historic, 2003-2010 61

Table 33: Bone Growth Stimulators, Brazil, Average Price ($), Forecast, 2010-2017 61

Table 34: Orthobiologics, Brazil, Distribution Share by Revenue ($m), 2009-2010 62

Table 35: Orthobiologics, Brazil, Company Share by Revenue ($m), 2009-2010 64

Table 36: Orthobiologics, Russian Federation, Overall Revenue ($m), 2003-2017 66

Table 37: Orthobiologics, Russian Federation, Overall Revenue ($m), Historic, 2003-2010 68

Table 38: Orthobiologics, Russian Federation, Overall Revenue ($m), Forecast, 2010-2017 70

Table 39: Orthobiologics, Russian Federation, Category Volume (Units), 2003-2017 71

Table 40: Orthobiologics, Russian Federation, Category Volume (Units), Historic, 2003-2010 73

Table 41: Orthobiologics, Russian Federation, Category Volume (Units), Forecast, 2010-2017 75

Table 42: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 77

Table 43: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 79

Table 44: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 81

Table 45: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 83

Table 46: Bone Graft Substitutes, Russian Federation, Average Price ($), Historic, 2003-2010 84

Table 47: Bone Graft Substitutes, Russian Federation, Average Price ($), Forecast, 2010-2017 84

Table 48: Bone Allografts, Russian Federation, Revenue ($m), Historic, 2003-2010 85

Table 49: Bone Allografts, Russian Federation, Revenue ($m), Forecast, 2010-2017 86

Table 50: Viscosupplementation, Russian Federation, Revenue ($m), Historic, 2003-2010 87

Table 51: Viscosupplementation, Russian Federation, Revenue ($m), Forecast, 2010-2017 88

Table 52: Viscosupplementation, Russian Federation, Volume (Units) Historic, 2003-2010 89

Table 53: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2010-2017 90

Table 54: Viscosupplementation, Russian Federation, Average Price ($), Historic, 2003-2010 91

Table 55: Viscosupplementation, Russian Federation, Average Price ($), Forecast, 2010-2017 91

Table 56: Bone Growth Stimulators, Russian Federation, Revenue ($m), Historic, 2003-2010 92

Table 57: Bone Growth Stimulators, Russian Federation, Revenue ($m), Forecast, 2010-2017 93

Table 58: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2003-2010 94

Table 59: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2010-2017 95

Table 60: Bone Growth Stimulators, Russian Federation, Average Price ($), Historic, 2003-2010 96

Table 61: Bone Growth Stimulators, Russian Federation, Average Price ($), Forecast, 2010-2017 96

Table 62: Orthobiologics, Russian Federation, Distribution Share by Revenue ($m), 2009-2010 97

Table 63: Orthobiologics, Russian Federation, Company Share by Revenue ($m), 2009-2010 99

Table 64: Orthobiologics, India, Overall Revenue ($m), 2003-2017 101

Table 65: Orthobiologics, India, Overall Revenue ($m), Historic, 2003-2010 103

Table 66: Orthobiologics, India, Overall Revenue ($m), Forecast, 2010-2017 105

Table 67: Orthobiologics, India, Category Volume (Units), 2003-2017 106

Table 68: Orthobiologics, India, Category Volume (Units), Historic, 2003-2010 108

Table 69: Orthobiologics, India, Category Volume (Units), Forecast, 2010-2017 109

Table 70: Bone Graft Substitutes, India, Revenue ($m) by Segment, Historic, 2003-2010 111

Table 71: Bone Graft Substitutes, India, Revenue ($m) by Segment, Forecast, 2010-2017 113

Table 72: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2003-2010 115

Table 73: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2010-2017 116

Table 74: Bone Graft Substitutes, India, Average Price ($), Historic, 2003-2010 117

Table 75: Bone Graft Substitutes, India, Average Price ($), Forecast, 2010-2017 117

Table 76: Viscosupplementation, India, Revenue ($m), Historic, 2003-2010 118

Table 77: Viscosupplementation, India, Revenue ($m), Forecast, 2010-2017 119

Table 78: Viscosupplementation, India, Volume (Units), Historic, 2003-2010 120

Table 79: Viscosupplementation, India, Volume (Units), Forecast, 2010-2017 121

Table 80: Viscosupplementation, India, Average Price ($), Historic, 2003-2010 122

Table 81: Viscosupplementation, India, Average Price ($), Forecast, 2010-2017 122

Table 82: Bone Allografts, India, Revenue ($m), Historic, 2003-2010 123

Table 83: Bone Allografts, India, Revenue ($m), Forecast, 2010-2017 124

Table 84: Bone Growth Stimulators, India, Revenue ($m), Historic, 2003-2010 125

Table 85: Bone Growth Stimulators, India, Revenue ($m), Forecast, 2010-2017 126

Table 86: Bone Growth Stimulators, India, Volume (Units), Historic, 2003-2010 127

Table 87: Bone Growth Stimulators, India, Volume (Units), Forecast, 2010-2017 128

Table 88: Bone Growth Stimulators, India, Average Price ($), Historic, 2003-2010 129

Table 89: Bone Growth Stimulators, India, Average Price ($), Forecast, 2010-2017 129

Table 90: Orthobiologics, India, Distribution Share by Revenue ($m), 2009-2010 130

Table 91: Orthobiologics, India, Company Share by Revenue ($m), 2009-2010 132

Table 92: Orthobiologics, China, Overall Revenue ($m), 2003-2017 134

Table 93: Orthobiologics, China, Overall Revenue ($m), Historic, 2003-2010 136

Table 94: Orthobiologics, China, Overall Revenue ($m), Forecast, 2010-2017 138

Table 95: Orthobiologics, China, Category Volume (Units), 2003-2017 139

Table 96: Orthobiologics, China, Category Volume (Units), Historic, 2003-2010 141

Table 97: Orthobiologics, China, Category Volume (Units), Forecast, 2010-2017 143

Table 98: Bone Graft Substitutes, China, Revenue ($m) by Segment, Historic, 2003-2010 145

Table 99: Bone Graft Substitutes, China, Revenue ($m) by Segment, Forecast, 2010-2017 147

Table 100: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2003-2010 149

Table 101: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2010-2017 151

Table 102: Bone Graft Substitutes, China, Average Price ($), Historic, 2003-2010 152

Table 103: Bone Graft Substitutes, China, Average Price ($), Forecast, 2010-2017 152

Table 104: Bone Allografts, China, Revenue ($m), Historic, 2003-2010 153

Table 105: Bone Allografts, China, Revenue ($m) by Segment, Forecast, 2010-2017 154

Table 106: Viscosupplementation, China, Revenue ($m), Historic, 2003-2010 155

Table 107: Viscosupplementation, China, Revenue ($m), Forecast, 2010-2017 156

Table 108: Viscosupplementation, China, Volume (Units), Historic, 2003-2010 157

Table 109: Viscosupplementation, China, Volume (Units), Forecast, 2010-2017 158

Table 110: Viscosupplementation, China, Average Price ($), Historic, 2003-2010 159

Table 111: Viscosupplementation, China, Average Price ($), Forecast, 2010-2017 159

Table 112: Bone Growth Stimulators, China, Revenue ($m), Historic, 2003-2010 160

Table 113: Bone Growth Stimulators, China, Revenue ($m), Forecast, 2010-2017 161

Table 114: Bone Growth Stimulators, China, Volume (Units), Historic, 2003-2010 162

Table 115: Bone Growth Stimulators, China, Volume (Units), Forecast, 2010-2017 163

Table 116: Bone Growth Stimulators, China, Average Price ($), Historic, 2003-2010 164

Table 117: Bone Growth Stimulators, China, Average Price ($), Forecast, 2010-2017 164

Table 118: Orthobiologics, China, Distribution Share by Revenue ($m), 2009-2010 165

Table 119: Orthobiologics, China, Company Share by Revenue ($m), 2009-2010 167

Table 120: Orthobiologics, South Africa, Overall Revenue ($m), 2003-2017 169

Table 121: Orthobiologics, South Africa, Overall Revenue ($m), Historic, 2003-2010 171

Table 122: Orthobiologics, South Africa, Overall Revenue ($m), Forecast, 2010-2017 173

Table 123: Orthobiologics, South Africa, Category Volume (Units), 2003-2017 174

Table 124: Orthobiologics, South Africa, Category Volume (Units), Historic, 2003-2010 176

Table 125: Orthobiologics, South Africa, Category Volume (Units), Forecast, 2010-2017 178

Table 126: Viscosupplementation, South Africa, Revenue ($m), Historic, 2003-2010 179

Table 127: Viscosupplementation, South Africa, Revenue ($m), Forecast, 2010-2017 180

Table 128: Viscosupplementation, South Africa, Volume (Units), Historic, 2003-2010 181

Table 129: Viscosupplementation, South Africa, Volume (Units), Forecast, 2010-2017 182

Table 130: Viscosupplementation, South Africa, Average Price ($), Historic, 2003-2010 183

Table 131: Viscosupplementation, South Africa, Average Price ($), Forecast, 2010-2017 183

Table 132: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 185

Table 133: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 187

Table 134: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2003-2010 189

Table 135: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2010-2017 190

Table 136: Bone Graft Substitutes, South Africa, Average Price ($), Historic, 2003-2010 191

Table 137: Bone Graft Substitutes, South Africa, Average Price ($), Forecast, 2010-2017 191

Table 138: Bone Allografts, South Africa, Revenue ($m), Historic, 2003-2010 192

Table 139: Bone Allografts, South Africa, Revenue ($m), Forecast, 2010-2017 193

Table 140: Bone Growth Stimulators, South Africa, Revenue ($m), Historic, 2003-2010 194

Table 141: Bone Growth Stimulators, South Africa, Revenue ($m), Forecast, 2010-2017 195

Table 142: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2003-2010 196

Table 143: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2010-2017 197

Table 144: Bone Growth Stimulators, South Africa, Average Price ($), Historic, 2003-2010 198

Table 145: Bone Growth Stimulators, South Africa, Average Price ($), Forecast, 2010-2017 198

Table 146: Orthobiologics, South Africa, Distribution Share by Revenue ($m), 2009-2010 199

Table 147: Orthobiologics, South Africa, Company Share by Revenue ($m), 2009-2010 201

Table 148: DePuy, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 203

Table 149: Genzyme Corporation, Revenue ($m), BRICS Orthobiologics Market, 2010 205

Table 150: Synthes, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 207

Table 151: Orthofix International N.V., Revenue ($m), BRICS Orthobiologics Market, 2010 209

Table 152: Medtronic, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 211

Table 153: Biomet, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 213

Table 154: DJO Incorporated Revenue ($m), BRICS Orthobiologics Market, 2010 215

Table 155: Smith & Nephew Plc, Revenue ($m), BRICS Orthobiologics Market, 2010 217

Table 156: Baxter International Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 219

Table 157: Stryker Corporation, Revenue ($m), BRICS Orthobiologics Market, 2010 221

Table 158: Globus Medical, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 222

Table 159: Wright Medical Group, Inc., Revenue ($m), BRICS Orthobiologics Market, 2010 224

Table 160: USD to Local Currency, BRICS, Average Exchange Rate, 2003-2010 233

1.2 List of Figures

Figure 1: Orthobiologics, BRICS, Overall Revenue ($m), 2003-2017 18

Figure 2: Orthobiologics, BRICS, Overall Revenue ($m), Historic, 2003-2010 20

Figure 3: Orthobiologics, BRICS, Overall Revenue ($m), Forecast, 2010-2017 22

Figure 4: Orthobiologics, BRICS, Category Volume (Units), 2003-2017 24

Figure 5: Orthobiologics, BRICS, Category Volume (Units), Historic, 2003-2010 25

Figure 6: Orthobiologics, BRICS, Category Volume (Units), Forecast, 2010-2017 27

Figure 7: Orthobiologics, BRICS, Company share (%), 2010 29

Figure 8: Orthobiologics, Brazil, Overall Revenue ($m), 2003-2017 31

Figure 9: Orthobiologics, Brazil, Overall Revenue ($m), Historic, 2003-2010 33

Figure 10: Orthobiologics, Brazil, Overall Revenue ($m), Forecast, 2010-2017 35

Figure 11: Orthobiologics, Brazil, Category Volume (Units), 2003-2017 37

Figure 12: Orthobiologics, Brazil, Category Volume (Units), Historic, 2003-2010 38

Figure 13: Orthobiologics, Brazil, Category Volume (Units), Forecast, 2010-2017 40

Figure 14: Bone Allografts, Brazil, Revenue ($m), Historic, 2003-2010 41

Figure 15: Bone Allografts, Brazil, Revenue ($m), Forecast, 2010-2017 42

Figure 16: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, Historic, 2003-2010 43

Figure 17: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, Forecast, 2010-2017 45

Figure 18: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2003-2010 47

Figure 19: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2010-2017 49

Figure 20: Viscosupplementation, Brazil, Revenue ($m), Historic, 2003-2010 52

Figure 21: Viscosupplementation, Brazil, Revenue ($m), Forecast, 2010-2017 53

Figure 22: Viscosupplementation, Brazil, Volume (Units), Historic, 2003-2010 54

Figure 23: Viscosupplementation, Brazil, Volume (Units), Forecast, 2010-2017 55

Figure 24: Bone Growth Stimulators, Brazil, Revenue ($m), Historic, 2003-2010 57

Figure 25: Bone Growth Stimulators, Brazil, Revenue ($m), Forecast, 2010-2017 58

Figure 26: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2003-2010 59

Figure 27: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2010-2017 60

Figure 28: Orthobiologics, Brazil, Company Share (%), 2010 63

Figure 29: Orthobiologics, Russian Federation, Overall Revenue ($m), 2003-2017 65

Figure 30: Orthobiologics, Russian Federation, Overall Revenue ($m), Historic, 2003-2010 67

Figure 31: Orthobiologics, Russian Federation, Overall Revenue ($m), Forecast, 2010-2017 69

Figure 32: Orthobiologics, Russian Federation, Category Volume (Units), 2003-2017 71

Figure 33: Orthobiologics, Russian Federation, Category Volume (Units), Historic, 2003-2010 72

Figure 34: Orthobiologics, Russian Federation, Category Volume (Units), Forecast, 2010-2017 74

Figure 35: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, Historic, 2003-2010 76

Figure 36: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, Forecast, 2010-2017 78

Figure 37: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic, 2003-2010 80

Figure 38: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast, 2010-2017 82

Figure 39: Bone Allografts, Russian Federation, Revenue ($m), Historic, 2003-2010 85

Figure 40: Bone Allografts, Russian Federation, Revenue ($m), Forecast, 2010-2017 86

Figure 41: Viscosupplementation, Russian Federation, Revenue ($m), Historic, 2003-2010 87

Figure 42: Viscosupplementation, Russian Federation, Revenue ($m), Forecast, 2010-2017 88

Figure 43: Viscosupplementation, Russian Federation, Volume (Units), Historic, 2003-2010 89

Figure 44: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2010-2017 90

Figure 45: Bone Growth Stimulators, Russian Federation, Revenue ($m), Historic, 2003-2010 92

Figure 46: Bone Growth Stimulators, Russian Federation, Revenue ($m), Forecast, 2010-2017 93

Figure 47: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2003-2010 94

Figure 48: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2010-2017 95

Figure 49: Orthobiologics, Russian Federation, Company Share (%), 2010 98

Figure 50: Orthobiologics, India, Overall Revenue ($m), 2003-2017 100

Figure 51: Orthobiologics, India, Overall Revenue ($m), Historic, 2003-2010 102

Figure 52: Orthobiologics, India, Overall Revenue ($m), Forecast, 2010-2017 104

Figure 53: Orthobiologics, India, Category Volume (Units), 2003-2017 106

Figure 54: Orthobiologics, India, Category Volume (Units), Historic, 2003-2010 107

Figure 55: Orthobiologics, India, Category Volume (Units), Forecast, 2010-2017 109

Figure 56: Bone Graft Substitutes, India, Revenue ($m) by Segment, Historic, 2003-2010 110

Figure 57: Bone Graft Substitutes, India, Revenue ($m) by Segment, Forecast, 2010-2017 112

Figure 58: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2003-2010 114

Figure 59: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2010-2017 116

Figure 60: Viscosupplementation, India, Revenue ($m), Historic, 2003-2010 118

Figure 61: Viscosupplementation, India, Revenue ($m), Forecast, 2010-2017 119

Figure 62: Viscosupplementation, India, Volume (Units), Historic, 2003-2010 120

Figure 63: Viscosupplementation, India, Volume (Units), Forecast, 2010-2017 121

Figure 64: Bone Allografts, India, Revenue ($m), Historic, 2003-2010 123

Figure 65: Bone Allografts, India, Revenue ($m), Forecast, 2010-2017 124

Figure 66: Bone Growth Stimulators, India, Revenue ($m), Historic, 2003-2010 125

Figure 67: Bone Growth Stimulators, India, Revenue ($m), Forecast, 2010-2017 126

Figure 68: Bone Growth Stimulators, India, Volume (Units), Historic, 2003-2010 127

Figure 69: Bone Growth Stimulators, India, Volume (Units), Forecast, 2010-2017 128

Figure 70: Orthobiologics, India, Company Share (%), 2010 131

Figure 71: Orthobiologics, China, Overall Revenue ($m), 2003-2017 133

Figure 72: Orthobiologics, China, Overall Revenue ($m), Historic, 2003-2010 135

Figure 73: Orthobiologics, China, Overall Revenue ($m), Forecast, 2010-2017 137

Figure 74: Orthobiologics, China, Category Volume (Units), 2003-2017 139

Figure 75: Orthobiologics, China, Category Volume (Units), Historic, 2003-2010 140

Figure 76: Orthobiologics, China, Category Volume (Units), Forecast, 2010-2017 142

Figure 77: Bone Graft Substitutes, China, Revenue ($m) by Segment, Historic, 2003-2010 144

Figure 78: Bone Graft Substitutes, China, Revenue ($m) by Segment, Forecast, 2010-2017 146

Figure 79: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2003-2010 148

Figure 80: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2010-2017 150

Figure 81: Bone Allografts, China, Revenue ($m), Historic, 2003-2010 153

Figure 82: Bone Allografts, China, Revenue ($m), Forecast, 2010-2017 154

Figure 83: Viscosupplementation, China, Revenue ($m), Historic, 2003-2010 155

Figure 84: Viscosupplementation, China, Revenue ($m), Forecast, 2010-2017 156

Figure 85: Viscosupplementation, China, Volume (Units), Historic, 2003-2010 157

Figure 86: Viscosupplementation, China, Volume (Units), Forecast, 2010-2017 158

Figure 87: Bone Growth Stimulators, China, Revenue ($m), Historic, 2003-2010 160

Figure 88: Bone Growth Stimulators, China, Revenue ($m), Forecast, 2010-2017 161

Figure 89: Bone Growth Stimulators, China, Volume (Units), Historic, 2003-2010 162

Figure 90: Bone Growth Stimulators, China, Volume (Units), Forecast, 2010-2017 163

Figure 91: Orthobiologics, China, Company Share (%), 2010 166

Figure 92: Orthobiologics, South Africa, Overall Revenue ($m), 2003-2017 168

Figure 93: Orthobiologics, South Africa, Overall Revenue ($m), Historic, 2003-2010 170

Figure 94: Orthobiologics, South Africa, Overall Revenue ($m), Forecast, 2010-2017 172

Figure 95: Orthobiologics, South Africa, Category Volume (Units), 2003-2017 174

Figure 96: Orthobiologics, South Africa, Category Volume (Units), Historic, 2003-2010 175

Figure 97: Orthobiologics, South Africa, Category Volume (Units), Forecast, 2010-2017 177

Figure 98: Viscosupplementation, South Africa, Revenue ($m), Historic, 2003-2010 179

Figure 99: Viscosupplementation, South Africa, Revenue ($m), Forecast, 2010-2017 180

Figure 100: Viscosupplementation, South Africa, Volume (Units), Historic, 2003-2010 181

Figure 101: Viscosupplementation, South Africa, Volume (Units), Forecast, 2010-2017 182

Figure 102: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, Historic, 2003-2010 184

Figure 103: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, Forecast, 2010-2017 186

Figure 104: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2003-2010 188

Figure 105: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2010-2017 190

Figure 106: Bone Allografts, South Africa, Revenue ($m), Historic, 2003-2010 192

Figure 107: Bone Allografts, South Africa, Revenue ($m), Forecast, 2010-2017 193

Figure 108: Bone Growth Stimulators, South Africa, Revenue ($m), Historic, 2003-2010 194

Figure 109: Bone Growth Stimulators, South Africa, Revenue ($m), Forecast, 2010-2017 195

Figure 110: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2003-2010 196

Figure 111: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2010-2017 197

Figure 112: Orthobiologics, South Africa, Company Share (%), 2010 200

Figure 113: DePuy, Inc., Company Share (%), BRICS Orthobiologics Market, 2010 203

Figure 114: Genzyme Corporation, Company Share (%), BRICS Orthobiologics Market, 2010 205

Figure 115: Synthes, Inc., Company Share (%), BRICS Orthobiologics Market, 2010 207

Figure 116:

To order this report:

Biomaterial Industry: Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Biomaterial Business News

More  Market Research Report

Check our  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com